PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)

CUSIP: 69353Y103

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COMMON STOCK
Shares outstanding
53,185,766
Total 13F shares
38,212,089
Share change
+2,496,465
Total reported value
$2,335,342,669
Price per share
$61.51
Number of holders
72
Value change
+$185,049,476
Number of buys
51
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q4 2020

As of 31 Dec 2020, PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,212,089 shares. The largest 10 holders included ORBIMED ADVISORS LLC, INTERWEST VENTURE MANAGEMENT CO, Euclidean Capital LLC, VIKING GLOBAL INVESTORS LP, Avoro Capital Advisors LLC, BOXER CAPITAL, LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, and VANGUARD GROUP INC. This page lists 72 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.